Dr. Jeremiah Brown Jr., MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 17319 Ih 35 N, Suite 303, Schertz, TX 78154 Phone: 210-693-1063 Fax: 830-214-2718 |
News Archive
Research assessing the safety and efficacy of hydroxyurea therapy in pediatric patients with sickle cell disease (SCD) and the use of pre-operative transfusions for patients with SCD who undergo low- and moderate-risk elective surgery will be presented today at the 53rd Annual Meeting of the American Society of Hematology.
The drought in the Horn of Africa "emphasizes the gap between our rapidly increasing ability to predict disasters, thanks largely to advances in science and technology, and our capacity to generate the political will to carry out effective mitigation strategies," according to a SciDev.Net opinion piece by editor David Dickson.
President Barack Obama promised to wage "a great campaign" in support of health reform, and he praised lawmakers who made "tough choices" with possible electoral consequences during the House Democrats' annual retreat Thursday on Capitol Hill, The Washington Post reports (Bacon, 1/15).
A new vaccine principle is being developed by scientists at the University of Copenhagen which - if it works to its full expected potential - could help to save millions of lives and revolutionise current vaccine technology.
Grifols, S.A. and Talecris Biotherapeutics Holdings Corp. announced today that the U.S. Federal Trade Commission has accepted for public comment a Consent Agreement that outlines the conditions necessary for Grifols' acquisition of Talecris to proceed.
› Verified 5 days ago